Andolong, Arlyne .
HRN: 24-07-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/07/2023
11/11/2023
IV
1.5g
Q6hrs
CAP-MR; T/c PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes